FDA Inspection
OneBlood - CrestviewOneBlood - Crestview – FDA Inspection, Apr 9, 2019
Record Details
This FDA Inspection record concerns OneBlood - Crestview, with an inspection on April 9, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 5fca8b1f-7699-4c80-ac68-2563e60192ee
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1086056
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 606.60(a)Equipment observed, standardized, calibrated
- 21 CFR 630.10(g)(1)Proof Of Identity
Full citation text and observation details available on the Dashboard.
Other FDA inspections of OneBlood - Crestview
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 29, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| February 3, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 3, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 31, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 31, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for OneBlood - Crestview
- FDA Inspection 1208645 - 2023-05-29
- FDA Inspection 1012287 - 2017-02-03
- FDA Inspection 941335 - 2015-09-03
- FDA Inspection 864463 - 2014-01-31
- FDA Inspection 817575 - 2013-01-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.